Register Now: Reshoring Maufacturing and Securing Cold-Chain Supply For Biopharma

News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

Ramesh Raju Mavuleti

Ramesh Raju Mavuleti*, rrajum@gmail.com, is head of operations, Validation Services India, at Merck Life Sciences Pvt, Ltd.

Articles by Ramesh Raju Mavuleti

Close-up of tubes in Brookhaven National Laboratory | Image Credit: © Bill Gallery - © Bill Gallery - stock.adobe.com

Application of the Risk Evaluation Matrix as per USP <665> and <1665> for Evaluation of Leachables Risk from Single-Use Components Used in Biomanufacturing

ByRamesh Raju Mavuleti,K. Vasantakumar Pa,K. Sreedhara Ranganath Pai,Subhasis Banerjee ,Somasundaram Gopalakrishnan,Tathagata Ray

June 6th 2024

Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.

bag of medical serum | Image Credit: © mailsonpignata - © mailsonpignata- Stock.adobe.com

Review of SUT Adoption in Biopharma Manufacturing

ByRamesh Raju Mavuleti,K. Vasantakumar Pa,K. Sreedhara Ranganath Pai,Subhasis Banerjee,Somasundaram Gopalakrishnan,Tathagata Ray

March 15th 2024

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Latest Updated Articles

Trending on BioPharm International

Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt

TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens

Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US

Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial

Zylidac Bio to Scale Prolific's Optogenetic Cell Line Platform to GMP